Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Hepatocellular 2 Thyroid Nodule 1 Prostatic Neoplasms 1 Multiple Pulmonary Nodules 1 Hyperaldosteronism 1 Carcinoma, Renal Cell 1 Bone Cancer Metastatic 1 Barrett Esophagus 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1 ACTH Syndrome, Ectopic 1

Interventions

Nivolumab 37 pembrolizumab 26 cabozantinib 26 Specimen Handling 23 Magnetic Resonance Spectroscopy 21 Ipilimumab 19 lenvatinib 13 belzutifan 13 Axitinib 13 CTLA-4 Antigen 10 Sunitinib 9 Radiosurgery 8 Biopsy 8 atezolizumab 7 fludarabine 4 avelumab 4 aldesleukin 4 Immunoglobulin G 4 Disulfides 4 zimberelimab 3 toripalimab 3 tivozanib 3 pazopanib 3 palbociclib 3 durvalumab 3 cemiplimab 3 Surveys and Questionnaires 3 Nephrectomy 3 Everolimus 3 Cyclophosphamide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Radiofrequency Ablation × 90 days × Clear all

NCT07465458 2026-03-16

RASROP-003

Humanitas Hospital, Italy

Not yet recruiting

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡